Second-line bevacizumab plus FOLFOX in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-based chemotherapy.

Chun, Sang Hoon; Kim, Jung Hoon; Kwag, Seung-Jin; Kang, Myoung Hee; Park, Ji-Ho; Lee, Gyeong-Won; Kang, Jung Hun

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

Second-line bevacizumab plus FOLFOX in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-based chemotherapy.

Authors: Chun, Sang Hoon; Kim, Jung Hoon; Kwag, Seung-Jin; Kang, Myoung Hee; Park, Ji-Ho; Lee, Gyeong-Won; Kang, Jung Hun

Issue Date: Feb-2023

Publisher: American Society of Clinical Oncology

Citation: Journal of Clinical Oncology, v.41, pp 157 - 157

Pages: 1

Indexed: SCIE
SCOPUS

Journal Title: Journal of Clinical Oncology

Volume: 41

Start Page: 157

End Page: 157

URI: https://scholarworks.gnu.ac.kr/handle/sw.gnu/68621

ISSN: 0732-183X
1527-7755

Files in This Item: There are no files associated with this item.

Appears in Collections: College of Medicine > Department of Medicine > Journal Articles

Show full item record

qrcode

Related Researcher

Researcher , photo

,

Read more

Altmetrics

Total Views & Downloads

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0534

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Related Researcher

Altmetrics

Total Views & Downloads

BROWSE